| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |